| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/CCLM.2004.248 |
| P698 | PubMed publication ID | 15576290 |
| P2093 | author name string | Marilyn A Huestis | |
| Robin E Choo | |||
| P2860 | cites work | The feasibility and acceptability of collecting oral fluid from healthy children for anti-HCV testing | Q27477821 |
| Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors | Q28185357 | ||
| Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers | Q28200976 | ||
| Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid | Q28370847 | ||
| Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration | Q28374065 | ||
| Biology and disease associations of Epstein-Barr virus | Q33772230 | ||
| A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma | Q33892498 | ||
| Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers | Q33922509 | ||
| Salivary cortisol as a tool for physiological studies and diagnostic strategies | Q34044627 | ||
| A comparison of serum and saliva paracetamol concentrations | Q34358506 | ||
| Review: therapeutic drug monitoring in pediatrics | Q34503248 | ||
| Diazepam and N-desmethyldiazepam concentrations in saliva, plasma and CSF | Q34518792 | ||
| Sensitivity, Specificity, and Efficiency in Detecting Opiates in Oral Fluid with the Cozart(R) Opiate Microplate EIA and GC-MS Following Controlled Codeine Administration | Q35579468 | ||
| Therapeutic drug monitoring in saliva. An update | Q35653966 | ||
| Drugs of abuse in saliva: a review. | Q36366065 | ||
| Developmental toxicity of valproic acid | Q37676812 | ||
| Salivary levels of anticonvulsants: A practical approach to drug monitoring | Q39145895 | ||
| Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH | Q39188125 | ||
| Oral absorption and secretion of drugs | Q39622573 | ||
| Hormones in saliva | Q39727802 | ||
| The role of saliva in drug monitoring | Q40769033 | ||
| Salivary IgA antigliadin antibody as a marker for coeliac disease | Q41127127 | ||
| Accuracy of Oral Specimen Testing for Human Immunodeficiency Virus | Q41526249 | ||
| Creatinine VIII: Saliva levels of endogenous “true” creatinine in normal subjects | Q41617381 | ||
| Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests | Q42581003 | ||
| Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots | Q43047682 | ||
| A comparison between on-site immunoassay drug-testing devices and laboratory results | Q43715584 | ||
| Comparison of point-of-collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen | Q43774601 | ||
| Salivary and urinary excretion and plasma-saliva concentration ratios of isoniazid in the presence of Co-administered ciprofloxacin. | Q43848903 | ||
| Role of salivary IgA in the pathogenesis of Sjögren syndrome | Q44078396 | ||
| Influence of menstrual cycle on the pharmacokinetics of paracetamol through salivary compartment in healthy subjects | Q44079798 | ||
| Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions | Q44123034 | ||
| Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations | Q44261993 | ||
| Correlation of levetiracetam concentrations between serum and saliva | Q44291451 | ||
| Topiramate concentration in saliva: an alternative to serum monitoring | Q44633284 | ||
| The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations | Q44648352 | ||
| Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting? | Q44672967 | ||
| Correlation of lamotrigine concentrations between serum and saliva | Q44705817 | ||
| Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates | Q45117910 | ||
| Development and evaluation of an antibody capture ELISA for detection of IgG to Epstein-Barr virus in oral fluid samples | Q45737730 | ||
| An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community | Q46557807 | ||
| Salivary Cortisol Levels throughout Childhood and Adolescence: Relation with Age, Pubertal Stage, and Weight | Q47357036 | ||
| Improved performance 4 hours after cocaine. | Q51146682 | ||
| Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis. | Q51374883 | ||
| Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. | Q51592313 | ||
| Salivary insulin concentrations in type 2 (non-insulin-dependent) diabetic patients and obese non-diabetic subjects: relationship to changes in plasma insulin levels after an oral glucose load. | Q51632559 | ||
| Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. | Q51653910 | ||
| Diazepam and N-desmethyldiazepam in saliva of hospital inpatients. | Q51877820 | ||
| The potential use of saliva to detect recurrence of disease in women with breast carcinoma. | Q52035118 | ||
| High sensitivity ELISA determination of taxol in various human biological fluids. | Q54060885 | ||
| Concentrations of Major Elements and Mercury in Unstimulated Human Saliva | Q57499807 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1273-1287 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Clinical Chemistry and Laboratory Medicine | Q5133754 |
| P1476 | title | Oral fluid as a diagnostic tool | |
| P478 | volume | 42 |
| Q44339136 | A Novel Chronic Opioid Monitoring Tool to Assess Prescription Drug Steady State Levels in Oral Fluid |
| Q50016064 | A descriptive systematic review of salivary TDM in neonates and infants |
| Q43006505 | A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications |
| Q38560254 | Alternative Sampling Strategies for Cytochrome P450 Phenotyping. |
| Q47285512 | An approach to remove alpha amylase for proteomic analysis of low abundance biomarkers in human saliva |
| Q100473296 | Artificial oral fluid characterisation: potential for use as a reference matrix in drug testing |
| Q57171932 | Biospecimens and the ABCD study: Rationale, methods of collection, measurement and early data |
| Q37029564 | Cannabinoid stability in authentic oral fluid after controlled cannabis smoking |
| Q37092157 | Current development of saliva/oral fluid-based diagnostics |
| Q35940339 | Current knowledge on cannabinoids in oral fluid |
| Q35053485 | Drug testing in oral fluid. |
| Q36319621 | Environmental tobacco smoke and stress as risk factors for miscarriage and preterm births |
| Q37197080 | Evaluation of Salivary Profile among Adult Type 2 Diabetes Mellitus Patients in South India |
| Q46853173 | Evaluation of a novel standardized system for collection and quantification of oral fluid |
| Q34025985 | Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration |
| Q51097951 | Fluorescence-based lateral flow assays for rapid oral fluid roadside detection of cannabis use. |
| Q47384175 | Illicit Drugs in Oral Fluid: Evaluation of Two Collection Devices |
| Q36748917 | Interpretation of oral fluid tests for drugs of abuse |
| Q36883069 | Long-term effect of tobacco on unstimulated salivary pH. |
| Q34448467 | Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence |
| Q35844154 | Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients |
| Q33915426 | Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge |
| Q35190524 | Oral fluid testing for drugs of abuse |
| Q36922212 | Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping |
| Q53463490 | Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. |
| Q46111758 | Quantitative analysis via Surface Enhanced Raman Scattering from Ag nano-colloids utilizing an oscillating cell and right-angle collection geometry. |
| Q83835202 | Salivary and serum interleukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population |
| Q58801226 | Salivary beta-endorphin and substance P are not biomarkers of neuropathic chronic pain propensity |
| Q42616194 | Salivary constituents and acidogenic microbial counts in coronary artery bypass graft patients from baseline to three-years after operation |
| Q47415985 | Salivary glutamate is elevated in individuals with chronic migraine. |
| Q36691563 | Salivary mRNA targets for cancer diagnostics |
| Q36748921 | The use of oral fluid for therapeutic drug management: clinical and forensic toxicology |
| Q36181187 | The use of salivary cytokines as a screening tool for oral squamous cell carcinoma : A review of the literature |
| Q34008868 | Use of alcohol and drugs by Norwegian employees: a pilot study using questionnaires and analysis of oral fluid |
Search more.